Home » Novartis Meningococcal Vaccine Menveo Protects Infants in Study
Novartis Meningococcal Vaccine Menveo Protects Infants in Study
Novartis AG’s Menveo vaccine provoked an immune response to four main strains of a meningitis-causing disease in infants, potentially offering protection against brain and spinal cord infections.
Bloomberg
Bloomberg
Upcoming Events
-
07May
-
14May
-
30May